Because MYC is a central regulator of the cell cycle and aberrant MYC expression plays a central role in oncogenesis [83], Kress and colleagues investigated the state of MK5 expression in tumour cells with increased MYC levels. The gene discussed is MAPKAPK5; the disease is neoplasm.